Bicara Therapeutics BCAX Business Segments — Professional fees
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Bicara Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProfessionalFees.
The official record: Bicara Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Bicara Therapeutics's business segments — professional fees.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Bicara Therapeutics's business segments — professional fees?
- Bicara Therapeutics (BCAX) reported business segments — professional fees of $3.56M in Q1 2026.
- How has Bicara Therapeutics's business segments — professional fees changed year-over-year?
- Bicara Therapeutics's business segments — professional fees increased by 136.7% year-over-year, from $1.5M to $3.56M.
- What is the long-term trend for Bicara Therapeutics's business segments — professional fees?
- Over 2 years (2023 to 2025), Bicara Therapeutics's business segments — professional fees has grown at a 69.3% compound annual growth rate (CAGR), from $2.06M to $5.91M.
- What does business segments — professional fees mean?
- Represents payments made to external consultants, legal counsel, auditors, and other professional service providers. These costs are essential for maintaining corporate governance, regulatory compliance, and specialized operational support.